The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Abstract excerpt

During the past 20 years our understanding of the control of breast tumor development, growth and survival has changed dramatically. The once long forgotten application of high dose synthetic estrogen therapy as the first chemical therapy to treat any cancer has been resurrected, refined and reinvented as the new biology of estrogen-induced apoptosis. High dose estrogen therapy was cast aside once tamoxifen, from...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apoptosis
• Share to Breast Neoplasms